On June 16h, 2022, P95 turned 11 years old! To everyone who has allowed our company to achieve this milestone, thank you! We are so excited to celebrate one more year doing what believe in: finding, analysing and reporting epidemiological data to help health agencies, research organisations and pharma companies in their quest to improve people’s access to safe and effective vaccines. We are proud of the achievements that the past 11 years have brought and look forward to the future. Here’s to many more years working together, new wonderful projects and contributions to public health.
P95 Welcomes Laurence De Moerlooze as Chief Medical Officer to Oversee Clinical and Epidemiology Operations
P95 BV, an Ampersand Capital Partners portfolio company, is proud to announce the appointment of Laurence De Moerlooze as Chief Medical Officer (CMO).
0 Comments